BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30973978)

  • 1. Population Pharmacokinetics of Pemetrexed in Adult Non-Small Cell Lung Cancer in Indian Patients.
    Srinivasan M; Chaturvedula A; Fossler MJ; Patil A; Gota V; Prabhash K
    J Clin Pharmacol; 2019 Sep; 59(9):1216-1224. PubMed ID: 30973978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian variability of pharmacokinetics of cisplatin in patients with non-small-cell lung carcinoma: analysis with the NONMEM program.
    Chen R; Li J; Hu WW; Wang ML; Zou SL; Miao LY
    Cancer Chemother Pharmacol; 2013 Nov; 72(5):1111-23. PubMed ID: 24061864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetic analysis of ten phase II clinical trials of pemetrexed in cancer patients.
    Latz JE; Chaudhary A; Ghosh A; Johnson RD
    Cancer Chemother Pharmacol; 2006 Apr; 57(4):401-11. PubMed ID: 16322991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of pemetrexed disodium (ALIMTA) in patients with cancer.
    Ouellet D; Periclou AP; Johnson RD; Woodworth JR; Lalonde RL
    Cancer Chemother Pharmacol; 2000; 46(3):227-34. PubMed ID: 11021740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis.
    de Rouw N; Croes S; Posthuma R; Agterhuis DE; Schoenmaekers JJAO; Derijks HJ; Burger DM; Dingemans AM; Ter Heine R
    Lung Cancer; 2019 Apr; 130():156-158. PubMed ID: 30885337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemetrexed exposure predicts toxicity in advanced non-small-cell lung cancer: A prospective cohort study.
    Visser S; Koolen SLW; de Bruijn P; Belderbos HNA; Cornelissen R; Mathijssen RHJ; Stricker BH; Aerts JGJV
    Eur J Cancer; 2019 Nov; 121():64-73. PubMed ID: 31561135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparative Pharmacokinetic Study of 2 Pemetrexed Formulations in Indian Adult Chemonaive Patients With Adenocarcinoma Stage III/IV Non-Small Cell Lung Cancer.
    Kavathiya K; Gurjar M; Patil A; Naik M; Noronha V; Joshi A; Gota V; Prabhash K
    Clin Pharmacol Drug Dev; 2017 May; 6(3):234-239. PubMed ID: 28371303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of platinum after nedaplatin administration and model validation in adult patients.
    Ishibashi T; Yano Y; Oguma T
    Br J Clin Pharmacol; 2003 Aug; 56(2):205-13. PubMed ID: 12895194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics meta-analysis of plitidepsin (Aplidin) in cancer subjects.
    Nalda-Molina R; Valenzuela B; Ramon-Lopez A; Miguel-Lillo B; Soto-Matos A; Perez-Ruixo JJ
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):97-108. PubMed ID: 18941750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of gentamicin in patients with cancer.
    Rosario MC; Thomson AH; Jodrell DI; Sharp CA; Elliott HL
    Br J Clin Pharmacol; 1998 Sep; 46(3):229-36. PubMed ID: 9764963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetic analysis of lanicemine (AZD6765), an NMDA channel blocker, in healthy subjects and patients with major depressive disorder.
    Agbo F; Bui KH; Zhou D
    J Clin Pharm Ther; 2017 Oct; 42(5):539-546. PubMed ID: 28474366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population analysis of the pharmacokinetics of Cremophor EL using nonlinear mixed-effect modelling.
    van den Bongard HJ; Mathôt RA; van Tellingen O; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2002 Jul; 50(1):16-24. PubMed ID: 12111107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Third-space fluid distribution of pemetrexed in non-small cell lung cancer patients.
    Honoré PH; Joensen SJ; Olsen M; Hansen SH; Mellemgaard A
    Cancer Chemother Pharmacol; 2014 Aug; 74(2):349-57. PubMed ID: 24934863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.
    Niioka T; Uno T; Yasui-Furukori N; Takahata T; Shimizu M; Sugawara K; Tateishi T
    Cancer Chemother Pharmacol; 2007 Apr; 59(5):575-80. PubMed ID: 16912889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetic meta-analysis of trabectedin (ET-743, Yondelis) in cancer patients.
    Perez-Ruixo JJ; Zannikos P; Hirankarn S; Stuyckens K; Ludwig EA; Soto-Matos A; Lopez-Lazaro L; Owen JS
    Clin Pharmacokinet; 2007; 46(10):867-84. PubMed ID: 17854236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of APOMINE: a meta-analysis in cancer patients and healthy males.
    Bonate PL; Floret S; Bentzen C
    Br J Clin Pharmacol; 2004 Aug; 58(2):142-55. PubMed ID: 15255796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetic analysis of patritumab, a HER3 inhibitor, in subjects with advanced non-small cell lung cancer (NSCLC) or solid tumors.
    Yoshiba S; Jansen M; Matsushima N; Chen S; Mendell J
    Cancer Chemother Pharmacol; 2016 May; 77(5):987-96. PubMed ID: 27017616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of PM00104 (Zalypsis(®)) in cancer patients.
    Pérez-Ruixo C; Valenzuela B; Fernández Teruel C; González-Sales M; Miguel-Lillo B; Soto-Matos A; Pérez-Ruixo JJ
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):15-24. PubMed ID: 21590449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.